论文部分内容阅读
将72例高血压脑出血急性期患者，随机分为治疗组41例和对照组对例，治疗组采用灯盏注射液和常规西药治疗，总有效率90．24％，愈显率56．1％，对照组采用常规西药治疗，其总有效率和愈显率分别为67．74％和29％，经统计学处理差异有显著性（PMO．05），在血肿吸收及神经功能缺损程度恢复方面治疗组优于对照组（P＜O．05），提示灯盏花注射液治疗高血压脑出血疗效优于常规西药治疗。
The 72 patients with acute cerebral hemorrhage in hypertensive patients were randomly divided into treatment group 41 cases and control group, the treatment group using Dengzhan injection and conventional western medicine, the total effective rate was 90.24%, the more effective rate was 56.1% , The control group with conventional western medicine, the total effective rate and the curent rate were 67.74% and 29%, respectively, the difference was statistically significant (PMO.05), in the hematoma absorption and recovery of neurological deficits The treatment group was better than the control group (P <0.05), suggesting that Erigeron Injection treatment of hypertensive intracerebral hemorrhage is superior to conventional western medicine.